Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study). - Rizzo M; Buti S; Fiala O; Incorvaia L; Molina-Cerrillo J; Bourlon MT; Fukuokaya W; Urabe F; Park SH; Mayrhofer K; Pichler R; Niedersuess-Beke D; et al. (Targeted oncology, 2026)